[Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver].
D000107:Acetylation; D000995:Antitubercular Agents / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D012293:Rifampin / Q000009:adverse effects; D000637:Transaminases / Q000378:metabolism; D014376:Tuberculosis / Q000188:drug therapy
D000995:Antitubercular Agents; D000637:Transaminases; D007538:Isoniazid; D012293:Rifampin
Hepatotoxizität der tuberkulostatischen Kombination INH + RMP + EMB in Beziehung zum Arzneistoffwechsel der Leber.